About Indonesia Energy Corp. Ltd. Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between ...
Medicus Pharma (NASDAQ:MDCX) earlier this week outlined further progress in its Skinject program following the release of Phase 2 topline data, alongside independent validation from a leading ...
The Artemis II astronauts are on their way toward the moon and beyond Earth's orbit after the Orion capsule performed a translunar injection burn. Now that the Artemis II astronauts are leaving Earth ...
WASHINGTON — NASA's moon-bound astronauts have left Earth's orbit and are en route to our planet's celestial neighbor. The Orion spacecraft kicked on its main engine for nearly six minutes, providing ...
NICE has recommended Wegovy ® (semaglutide injection) 2.4 mg as the first GLP-1 RA to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or ...
Artemis 2's Orion capsule is scheduled to conduct a crucial engine burn this evening (April 2) that will send it to the moon. When you purchase through links on our site, we may earn an affiliate ...
PHILADELPHIA, April 01, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs ...
The US Food and Drug Administration (FDA) has approved Novo Nordisk’s insulin injection Awiqli to control blood sugar levels in adults living with Type 2 diabetes, the company said on March 26. Novo ...
March 26 (Reuters) - The U.S. Food and Drug Administration has approved Novo Nordisk's (NOVOb.CO), opens new tab insulin injection, Awiqli, to control blood sugar levels in adults living with type 2 ...
Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid immediate surgical intervention. PHILADELPHIA, PA / ACCESS ...
A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results